Nanna Therapeutics is a small-molecule focused therapeutics biotech subsidiary of Astellas, a Japanese global pharmaceutical company. Nanna and Mitobridge together comprise of the Mitobridge Division, a US- and UK-based research engine of Astellas reporting in to the Astellas Chief Scientific Officer, together we work as part of the Astellas Primary Focus Mitochondria area of research. Mitobridge is a Boston-based biotech acquired by Astellas in 2018, and Nanna Therapeutics, is a Cambridge, UK-based biotech, acquired in 2020. Further information can be found at www.nannatherapeutics.com.
Looking for a particular Nanna Therapeutics employee's phone or email?
Nanna Therapeutics Questions
The Nanna Therapeutics annual revenue was $3 million in 2026.
2 people are employed at Nanna Therapeutics.
The NAICS codes for Nanna Therapeutics are [541711, 32, 325, 5417, 541, 54, 54171].
The SIC codes for Nanna Therapeutics are [283, 2834, 28].
Top Nanna Therapeutics Employees
-
Sarah Almond
Head Of Pharmacology at Nanna Therapeutics
Cambridge, Cambridgeshire, United Kingdom1 -
1
Related Companies
